Alcoholic Liver Disease Replaces Hepatitis C Virus Infection as the Leading Indication for Liver Transplantation in the United States
Authors:
Top Cited Papers
- 1 August 2018
- journal article
- letter
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 16 (8) , 1356-1358
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Improved Outcomes in HCV Patients Following Liver Transplantation During the Era of Direct-Acting Antiviral AgentsClinical Gastroenterology and Hepatology, 2018
- Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013JAMA Psychiatry, 2017
- Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver TransplantationGastroenterology, 2017
- Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapyHepatology, 2016
- Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United StatesAnnals of Internal Medicine, 2015